These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 19373965)

  • 1. Giant osteoclast formation and long-term oral bisphosphonate therapy.
    Roos JC; Cox TM
    N Engl J Med; 2009 Apr; 360(16):1676-7; author reply 1677-8. PubMed ID: 19373965
    [No Abstract]   [Full Text] [Related]  

  • 2. Giant osteoclast formation and long-term oral bisphosphonate therapy.
    Jobke B
    N Engl J Med; 2009 Apr; 360(16):1676; author reply 1677-8. PubMed ID: 19369677
    [No Abstract]   [Full Text] [Related]  

  • 3. The deceiving appearances of osteoclasts.
    Glowacki J
    N Engl J Med; 2009 Jan; 360(1):80-2. PubMed ID: 19118309
    [No Abstract]   [Full Text] [Related]  

  • 4. Giant osteoclast formation and long-term oral bisphosphonate therapy.
    Weinstein RS; Roberson PK; Manolagas SC
    N Engl J Med; 2009 Jan; 360(1):53-62. PubMed ID: 19118304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the osteoclast in cranial suture waveform patterning.
    Byron CD
    Anat Rec A Discov Mol Cell Evol Biol; 2006 May; 288(5):552-63. PubMed ID: 16604542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis.
    Armamento-Villareal R; Napoli N; Panwar V; Novack D
    N Engl J Med; 2006 Nov; 355(19):2048-50. PubMed ID: 17093260
    [No Abstract]   [Full Text] [Related]  

  • 7. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
    Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
    Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiremodeling agents influence osteoblast activity differently in modeling and remodeling sites of canine rib.
    Allen MR; Follet H; Khurana M; Sato M; Burr DB
    Calcif Tissue Int; 2006 Oct; 79(4):255-61. PubMed ID: 17033724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alendronate on tooth eruption and molar root formation in young growing rats.
    Bradaschia-Correa V; Massa LF; Arana-Chavez VE
    Cell Tissue Res; 2007 Dec; 330(3):475-85. PubMed ID: 17901984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of local delivery of alendronate on bone formation in bioactive glass grafting in rats.
    Srisubut S; Teerakapong A; Vattraphodes T; Taweechaisupapong S
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):e11-6. PubMed ID: 17656137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological evaluation of indolyl bisphosphonates as anti-bone resorptive and anti-leishmanial agents.
    Singh US; Shankar R; Kumar A; Trivedi R; Chattopadhyay N; Shakya N; Palne S; Gupta S; Hajela K
    Bioorg Med Chem; 2008 Sep; 16(18):8482-91. PubMed ID: 18752963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A histopathological investigation on the effects of the bisphosphonate alendronate on resorptive phase following mucoperiosteal flap surgery in the mandible of rats.
    Kaynak D; Meffert R; Günhan M; Günhan O; Ozkaya O
    J Periodontol; 2000 May; 71(5):790-6. PubMed ID: 10872961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alendronate affects osteoblast functions by crosstalk through EphrinB1-EphB.
    Shimizu E; Tamasi J; Partridge NC
    J Dent Res; 2012 Mar; 91(3):268-74. PubMed ID: 22180568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of distortion of vascular deprivation-induced osteonecrosis of the rat femoral head by treatment with alendronate.
    Peled E; Bejar J; Zinman C; Boss JH; Reis DN; Norman D
    Arch Orthop Trauma Surg; 2009 Feb; 129(2):275-9. PubMed ID: 18523789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of nitrogen-containing bisphosphonates on osteoclasts and osteoclastogenesis: an ultrastructural study.
    Takagi Y; Inoue S; Fujikawa K; Matsuki-Fukushima M; Mayahara M; Matsuyama K; Endo Y; Nakamura M
    Microscopy (Oxf); 2021 Jun; 70(3):302-307. PubMed ID: 33277903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of hyperbaric oxygen in treatment of bisphosphonate-related osteonecrosis of the jaws.
    Freiberger JJ
    J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):96-106. PubMed ID: 19371820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Comparison of Osteoblast and Osteoclast In Vitro Co-Culture Models and Their Translation for Preclinical Drug Testing Applications.
    Sieberath A; Della Bella E; Ferreira AM; Gentile P; Eglin D; Dalgarno K
    Int J Mol Sci; 2020 Jan; 21(3):. PubMed ID: 32019244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of pH on osteoclasts treated with zoledronate and alendronate.
    Manzano-Moreno FJ; Ramos-Torrecillas J; de Luna-Bertos E; Illescas-Montes R; Arnett TR; Ruiz C; García-Martínez O
    Clin Oral Investig; 2019 Feb; 23(2):813-820. PubMed ID: 29876664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem cells and osteoporosis therapy.
    Teitelbaum SL
    Cell Stem Cell; 2010 Nov; 7(5):553-4. PubMed ID: 21040895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quercetin and alendronate multi-functionalized materials as tools to hinder oxidative stress damage.
    Forte L; Torricelli P; Boanini E; Rubini K; Fini M; Bigi A
    J Biomed Mater Res A; 2017 Dec; 105(12):3293-3303. PubMed ID: 28865182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.